Efficacy and safety of first-line therapy with chlorambucil, rituximab and lenalidomide (Revlimid®) (CR2) in elderly patients and young frail patients with advanced Chronic Lymphocytic Leukemia (CLL): A phase II trial.
Phase of Trial: Phase II
Latest Information Update: 29 Apr 2014
At a glance
- Drugs Lenalidomide (Primary) ; Chlorambucil; Rituximab
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 15 Sep 2011 New trial record